From the Departments of Ultrasound (X.M.B., W.Y., H.W., S.W., Z.Y.Z., W.W., M.H.C., K.Y.) and Oncology Surgery (M.C.), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, No. 52 Fucheng Rd, District of Haidian, Beijing 100142, China; and Division of Image-Guided Therapy, Department of Radiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel (S.N.G.).
Auto-generated profile, based on publicly available information
Wei Yang
From the Departments of Ultrasound (X.M.B., W.Y., H.W., S.W., Z.Y.Z., W.W., M.H.C., K.Y.) and Oncology Surgery (M.C.), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, No. 52 Fucheng Rd, District of Haidian, Beijing 100142, China; and Division of Image-Guided Therapy, Department of Radiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel (S.N.G.).
Outcomes of radiofrequency ablation in the curative treatment of solitary hepatocellular carcinoma 5 cm or smaller are equivalent regardless of initial procedure or salvage therapy. Background Although favorable outcomes have been reported with radiofrequency ablation (RFA) for limited hepatocellular carcinoma (HCC), the efficacy of this treatment for recurrent HCC has not bee...